Aceso Life Science Group Limited (0474.HK) HKSE

0.12

-0.003(-2.52%)

Updated at December 04 04:08PM

Currency In HKD

Valuation

Market Cap367.05M
Enterprise Value2.54B
P/E Ratio-0.95
PEG Ratio0.02
Price/Sales Ratio4.37
Price/Book Ratio71.16
Enterprise/Revenue15.49
Enterprise/EBITDA-16.87

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-4.59
Operating Margin-0.12

Management Effectiveness

Return On Assets-0.28
Return On Equity-2.21

Income Statement

Revenue195M
Revenue/Share0.03
Gross Profit90M
EBITDA-860M
Net Income-895M
Diluted EPS-0.12

Balance Sheet

Total Cash207M
Total Cash/Share0.03
Total Debt2.3B
Total Debt/Equity191.75
Current Ratio0.28
Book Value Per Share0.1

Price History

52-Week Change124.53
52-Week High0.13
52-Week Low0.02
Moving Average 50 Days0.1
Moving Average 200 Days0.05

Statistics

Average Volume43.21M
Shares Outstanding7.15B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor7:6
Last Split DateJuly 12, 2017